Gelesis
Boston, US · Delaware corporation · 2 known investors
Gelesis develops biomimicry-based, nature-inspired therapeutics aimed at addressing unmet medical needs and major health challenges. The company operates in the biotech/therapeutics industry.
Founders & leadership
MF
Meghan FitzgeraldDirector
JL
John LaMattinaDirector
RF
Robert ForresterDirector
YZ
Yishai ZoharDirector, President, and Chief Executive Officer
EM
Elliot MaltzTreasurer
EB
Elon BomsDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$31.5MraisedDec 2015 · 6 investors · BiotechnologyRule 506(c)
▶$31.5MraisedDec 2015 · 6 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Meghan FitzgeraldDirector
- John LaMattinaDirector
- Elon BomsDirector
- Robert ForresterDirector
- Yishai ZoharExecutive Officer, Director
- Elliot MaltzExecutive Officer
- Offering amount
- $34M
- Amount sold
- $31.5M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.